Outcome of Autologous Hematopoietic Stem Cell Transplantation in Refractory Multiple Myeloma

BACKGROUND: Despite the introduction of effective novel agents, the outcome of patients with refractory multiple myeloma remains poor, particularly those refractory to both proteasome inhibitors (PIs) and immunomodulatory agents (IMiDs). Limited data is available on the role of autologous hematopoie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Veltri, Lauren W., Milton, Denái R., Delgado, Ruby, Shah, Nina, Patel, Krina, Nieto, Yago, Kebriaei, Partow, Popat, Uday R., Parmar, Simrit, Oran, Betul, Ciurea, Stefan, Hosing, Chitra, Lee, Hans C., Manasanch, Elisabet, Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H., Bashir, Qaiser
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656242/
https://ncbi.nlm.nih.gov/pubmed/28513828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30770
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados